N-acetylcysteine (NAC) as an adjunct to intravenous fibrinolysis in patients with acute ischemic stroke: a single group study (NAC-Safety)
- 10 August 2025
- journal article
- Published by Elsevier in Neuroscience
- Vol. 584, 107-112
Abstract
No abstract availableKeywords
Funding Information
- French National Research Agency (ANR-18-RHUS-0001)
This publication has 8 references indexed in Scilit:
- R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin ComponentsStroke, 2024
- Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS)Scientific Reports, 2024
- Potent Thrombolytic Effect of N -Acetylcysteine on Arterial ThrombiCirculation, 2017
- A simple formula for the calculation of sample size in pilot studiesJournal of Clinical Epidemiology, 2015
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- Laboratory Testing for von Willebrand Disease: Contribution of Multimer Analysis to Diagnosis and ClassificationSeminars in Thrombosis and Hemostasis, 2006
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988